| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.014 | 0.9 |